Dale Pfost

General Partner

Dale joined Advent in 2010 bringing 25 years of experience as a serial entrepreneur and executive in life sciences.

He holds a BS degree from the University of California and a PhD in Physics from Brown University. Dale's first Company which he founded while still in graduate school, was acquired by SmithKline Beckman. He has been founding CEO and Chairman of Oxford GlycoSciences (IPO on LSE and NASDAQ), Orchid BioSciences (IPO on NASDAQ) and of Acuity Pharmaceuticals, an innovative ophthalmology Company acquired by OPKO Health (NASDAQ: OPK), and CEO of Receptor BioLogix.

Since joining Advent, Dale has been involved with several portfolio Companies, including CN Creative, Vestagen and Aura BioSciences.

View Dale's profile on LinkedIn

Assistant: Diana Parton
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +44 (0)20 7932 2147